Karyopharm Therapeutics Inc. buy Cantor Fitzgerald
Start price
09.06.26
/
50%
€0.54
Target price
09.06.27
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 09.06.27. The prediction end date can be changed by Cantor_Fitzgerald at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Karyopharm Therapeutics Inc. | - | - |
| iShares Core DAX® | -1.087% | 0.196% |
| iShares Nasdaq 100 | -2.463% | -1.792% |
| iShares Nikkei 225® | -5.371% | -5.434% |
| iShares S&P 500 | -0.197% | 1.767% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics (KPTI) had its "overweight" rating reaffirmed by Cantor Fitzgerald.
Ratings data for KPTI provided by MarketBeat